Vascular Disrupting Agents Market Size is predicted to grow at an 10% CAGR during the forecast period for 2029-2034. Vascular disrupting agents (VDAs) are a novel family of medications that target the existing tumour vasculature and cause tumour necrosis. As the world's population has aged, so has the global burden of cancer morbidity and mortality. Cancer is the primary or second leading cause of death among persons under the age of 70 ...
Report ID: 1299 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Hospital Energy Management Solutions Market Size predicted to reach represent a 8.5% CAGR during the forecast period for 2025-2034. Hospital Energy Management Systems (HEMS) optimize energy use in healthcare facilities, aiming to cut operational costs, boost patient comfort, and lessen environmental impact. These systems integrate advanced technology and strategies to manage energy consumption efficiently. Key elements include energy monitorin...
Report ID: 2349 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 179
ATMPs Consulting Market Size is predicted to witness a 8.6% CAGR during the forecast period for 2025-2034. Advanced therapy medical products (ATMPs) are human medicines based on genes, tissues, or cells. They provide new and novel therapeutic options for ailments and injuries. ATMPs primarily target diseases with significant unmet medical needs. The introduction of ATMPs has altered the pharmaceutical industry as well as the illness treatment la...
Report ID: 2152 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Cannabis Inhaler Market is expected to grow at a 9.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the report: The advent of the cannabis inhaler market is the cause of regulatory changes, technological advancements, changing consumer preferences, and increasing acceptance. The increasing demand for smoke-free alternatives is expected to drive industry growth. North America dominated the market ...
Report ID: 1417 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 190
Immunoturbidimetry Reagents Market Size is predicted to represent a 7.2% CAGR during the forecast period for 2025-2034. Immunoturbidimetry (IT) is a valuable diagnostic tool in clinical chemistry. It's utilized to find blood proteins that aren't detectable using typical clinical chemistry methods or the antigen-antibody reaction. Immunoturbidimetry is based on antigen-antibody interactions that are specific and sensitive. Each antibody recogni...
Report ID: 2200 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Leukemia Inhibitory Factor (LIF) Market Size is valued at USD 1.29 Bn in 2024 and is predicted to reach USD 3.02 Bn by the year 2034 at a 9.0% CAGR during the forecast period for 2025-2034. One of the cytokines in the interleukin-6 family, leukemia inhibitory factor (LIF), is essential for controlling differentiation, proliferation, and survival, among other cellular functions. In a variety of medical applications, including chronic inflammato...
Report ID: 3018 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Healthcare Management Service Organization (MSO) Market Size is predicted to grow at an 10.9% CAGR during the forecast period for 2024-2031. Management services organizations (MSOs) are administrative and management entities that provide a range of services to healthcare providers. They offer different types of governance, structure, and function tailored to the needs of individual practice associations (IPAs) or medical groups. Healthcare pro...
Report ID: 2531 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Global COVID-19 Therapeutics Market is expected to grow at a 15.0% CAGR during the forecast period for 2025-2034. The increasing outbreak of covid-19 is increasing the demand for coronavirus vaccines or therapies, which will result in the expansion of the COVID-19 therapeutics market during the forecast period. According to the World Health Organization (WHO), globally, 175,847,347 confirmed cases of COVID-19, including 3,807,276 deaths, were re...
Report ID: 1184 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 190
Global TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market Size is predicted to expand at a 9.8% CAGR during the forecast period for 2025-2034. The surge in cancer prevalence and the trend toward personalized treatment serve as the primary drivers of market expansion. The quest for novel therapeutic targets is imperative to offer improved treatment options for the escalating number of cancer cases. TROP2 has eme...
Report ID: 2493 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Global Triple-Negative Breast Cancer Treatment Market Size is estimated to grow at a 5.2% CAGR during the forecast period for 2025-2034. Triple-Negative Breast Cancer is classified as a type of breast cancer wherein tumors lack progesterone receptor (PR), the estrogen receptor (ER), and human epidermal growth factor receptor 2 (HER2), and hence still there are no effective treatment methods for TNBC. TNBC is the leading cause of death in women. ...
Report ID: 1038 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Pharmaceuticals